Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07782346 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Liposomal Irinotecan Plus Cisplatin in Patients With Advanced or Metastatic Solid Malignancies

Study acronym: ICONIC
StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial sites expanded: 0 → 6 locations
    • Eligibility criteria expanded, about 21 words
    • Study title shortened, about 7 words
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Phase I trial, Multiple centers, open-label, non-randomized single-arm study
Trial Details
NCT Number NCT07782346
Lead Sponsor National Health Research Institutes, Taiwan
Collaborators: China Medical University Hospital, National Taiwan University Hospital, Taipei Veterans General Hospital, Taiwan, Mackay Memorial Hospital, National Cheng-Kung University Hospital, Taichung Veterans General Hospital, Chang Gung Memorial Hospital
Conditions
(from sponsor)		 Advanced Solid Malignancies
Enrollment 44 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov